Cargando…

TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity

Human regulatory macrophages (Mreg) have shown early clinical promise as a cell-based adjunct immunosuppressive therapy in solid organ transplantation. It is hypothesised that recipient CD4(+) T cell responses are actively regulated through direct allorecognition of donor-derived Mregs. Here we show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riquelme, Paloma, Haarer, Jan, Kammler, Anja, Walter, Lisa, Tomiuk, Stefan, Ahrens, Norbert, Wege, Anja K., Goecze, Ivan, Zecher, Daniel, Banas, Bernhard, Spang, Rainer, Fändrich, Fred, Lutz, Manfred B., Sawitzki, Birgit, Schlitt, Hans J., Ochando, Jordi, Geissler, Edward K., Hutchinson, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054648/ https://www.ncbi.nlm.nih.gov/pubmed/30030423 http://dx.doi.org/10.1038/s41467-018-05167-8

Ejemplares similares

In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
por: Broichhausen, Christiane, et al.
Publicado: (2014)

In-vitro inhibition of IFNγ(+) iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function
por: Daniel, Volker, et al.
Publicado: (2012)

Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
por: Hui, Zhenzhen, et al.
Publicado: (2021)

Cholesterol suppresses human iTreg differentiation and nTreg function through mitochondria-related mechanisms
por: Zhang, Huanzhi, et al.
Publicado: (2023)

Altered expression and editing of miRNA-100 regulates iTreg differentiation
por: Negi, Vinny, et al.
Publicado: (2015)

Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination
por: Schreiber, Taylor H., et al.
Publicado: (2012)

Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways
por: Lu, Yunjie, et al.
Publicado: (2014)

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers
por: Hutchinson, James A., et al.
Publicado: (2018)

Efficient induction of CD25(- )iTreg by co-immunization requires strongly antigenic epitopes for T cells
por: Geng, Shuang, et al.
Publicado: (2011)

Combined Treatment With TGF-β1, Retinoic Acid, and Lactoferrin Robustly Generate Inducible Tregs (iTregs) Against High Affinity Ligand
por: Jang, Young-Saeng, et al.
Publicado: (2023)

P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25− T Cells into iTreg
por: Huber, Samuel, et al.
Publicado: (2008)

CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro
por: Pilat, Nina, et al.
Publicado: (2018)

ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation
por: Tian, Miaomiao, et al.
Publicado: (2021)

IL-1 signaling modulates STAT activation to antagonize retinoic acid signaling and control Th17–iTreg balance
por: Basu, Rajatava, et al.
Publicado: (2015)

Arkadia-SKI/SnoN signaling differentially regulates TGF-β–induced iTreg and Th17 cell differentiation
por: Xu, Hao, et al.
Publicado: (2021)

Laser Ablation Inductively Coupled Plasma Mass Spectrometry: An Emerging Technology for Multiparametric Analysis of Tissue Antigens
por: Hutchinson, Robert W., et al.
Publicado: (2015)

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity
por: Xia, Meng, et al.
Publicado: (2017)

DHRS9 Is a Stable Marker of Human Regulatory Macrophages
por: Riquelme, Paloma, et al.
Publicado: (2017)

CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39
por: Zhang, Xiao, et al.
Publicado: (2019)

Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
por: Schilling, Hannah-Lou, et al.
Publicado: (2021)

The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4(+) T cells resembling iTreg
por: Tauber, Peter A., et al.
Publicado: (2023)

Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs
por: Riquelme, Paloma, et al.
Publicado: (2012)

Relevance and targeting of memory T cells in transplantation
por: Sawitzki, Birgit, et al.
Publicado: (2011)

TIGIT limits immune pathology during viral infections
por: Schorer, Michelle, et al.
Publicado: (2020)

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs
por: De Souza, Adriano Luís Soares, et al.
Publicado: (2018)

Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T cell responses during pulmonary viral infection
por: de Almeida Nagata, Denise E., et al.
Publicado: (2015)

Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells
por: Kojima, Marenori, et al.
Publicado: (2023)

TIGIT reverses IFN-α-promoted Th1-like Tregs via in-sequence effects dependent on STAT4
por: Yu, Shihan, et al.
Publicado: (2023)

TIGIT in cancer immunotherapy
por: Chauvin, Joe-Marc, et al.
Publicado: (2020)

Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4(+) Treg Cells in Patients with Rheumatoid Arthritis
por: Yang, Mengru, et al.
Publicado: (2019)

A2Ar-dependent PD-1+ and TIGIT+ Treg cells have distinct homing requirements to suppress autoimmune uveitis in mice
por: Peters, Kayleigh, et al.
Publicado: (2023)

Mild hypothermia provides Treg stability
por: Marek-Trzonkowska, Natalia, et al.
Publicado: (2017)

Author Correction: Mild hypothermia provides Treg stability
por: Marek- Trzonkowska, Natalia, et al.
Publicado: (2017)

TIGIT-based immunotherapeutics in lung cancer
por: Patel, Akshay J, et al.
Publicado: (2023)

DNAM1 and TIGIT balance the T cell response, with low T cell TIGIT expression corresponding to inflammation in psoriatic disease
por: Jacobs, Marleen E, et al.
Publicado: (2020)

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
por: Glehr, Gunther, et al.
Publicado: (2022)

Dynamic Expressions of TIGIT on Splenic T Cells and TIGIT-Mediated Splenic T Cell Dysfunction of Mice With Chronic Toxoplasma gondii Infection
por: Li, Haoran, et al.
Publicado: (2021)

High normal values of circulating immune cell subsets before surgery may be protective against development of postoperative acute kidney injury
por: Ehehalt, K, et al.
Publicado: (2015)

Mechanisms of TIGIT-driven immune suppression in cancer
por: Kurtulus, Sema, et al.
Publicado: (2014)

Expression of the immune checkpoint receptor TIGIT in seminoma
por: Hinsch, Andrea, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_holo6kmlg6h6pbr8a1a1pn276e